Oral hearings heard the USPTO side with MSD (Merck) over a term extension for a reissued patent, in a case set to have huge implications for pharma market exclusivity, reports Marisa Woutersen.
Whoop faces suit over tech in health tracker watch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback